These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 30065966)

  • 1. Harnessing nanostructured systems for improved treatment and prevention of HIV disease.
    Monroe M; Flexner C; Cui H
    Bioeng Transl Med; 2018 May; 3(2):102-123. PubMed ID: 30065966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanostructured Delivery Systems: Augmenting the Delivery of Antiretroviral Drugs for Better Management of HIV/AIDS.
    Singh G; Pai RS; Mustafa S
    Crit Rev Ther Drug Carrier Syst; 2015; 32(6):503-33. PubMed ID: 26559551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Trends in the Long-Acting Antiretroviral Therapy: Current Status and Therapeutic Challenges.
    Labh R; Gupta R
    Curr HIV Res; 2021; 19(1):4-13. PubMed ID: 32838720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments of nanotherapeutics for targeted and long-acting, combination HIV chemotherapy.
    Gao Y; Kraft JC; Yu D; Ho RJY
    Eur J Pharm Biopharm; 2019 May; 138():75-91. PubMed ID: 29678735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current therapy for human immunodeficiency virus infection and acquired immunodeficiency syndrome.
    Honda M; Oka S
    Int J Hematol; 2006 Jul; 84(1):18-22. PubMed ID: 16867897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obstacles to successful antiretroviral treatment of HIV-1 infection: problems & perspectives.
    Potter SJ; Chew CB; Steain M; Dwyer DE; Saksena NK
    Indian J Med Res; 2004 Jun; 119(6):217-37. PubMed ID: 15243161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    Ann Intern Med; 2002 Sep; 137(5 Pt 2):381-433. PubMed ID: 12617573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Overview of Antiretroviral Agents for Treating HIV Infection in Paediatric Population.
    Melo R; Lemos A; Preto AJ; Bueschbell B; Matos-Filipe P; Barreto C; Almeida JG; Silva RDM; Correia JDG; Moreira IS
    Curr Med Chem; 2020; 27(5):760-794. PubMed ID: 30182840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target Molecules and Delivery Vehicles for Anti-HIV Drugs In vitro and In vivo.
    Bolhassani A
    Curr Pharm Des; 2018; 24(29):3393-3401. PubMed ID: 29886823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update and review of antiretroviral therapy.
    Piacenti FJ
    Pharmacotherapy; 2006 Aug; 26(8):1111-33. PubMed ID: 16863488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Escape from Small-Molecule Antagonism of Vif.
    Sharkey M; Sharova N; Mohammed I; Huff SE; Kummetha IR; Singh G; Rana TM; Stevenson M
    mBio; 2019 Feb; 10(1):. PubMed ID: 30808702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-Term Pegylated Interferon α2a Treatment Does Not Significantly Reduce the Viral Reservoir of Simian Immunodeficiency Virus-Infected, Antiretroviral Therapy-Treated Rhesus Macaques.
    Palesch D; Bosinger SE; Mavigner M; Billingsley JM; Mattingly C; Carnathan DG; Paiardini M; Chahroudi A; Vanderford TH; Silvestri G
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29720521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral drug-S for a possible HIV elimination.
    Agas A; Schuetz H; Mishra V; Szlachetka AM; Haorah J
    Int J Physiol Pathophysiol Pharmacol; 2019; 11(4):149-162. PubMed ID: 31523362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanodrug formulations to enhance HIV drug exposure in lymphoid tissues and cells: clinical significance and potential impact on treatment and eradication of HIV/AIDS.
    Shao J; Kraft JC; Li B; Yu J; Freeling J; Koehn J; Ho RJ
    Nanomedicine (Lond); 2016; 11(5):545-64. PubMed ID: 26892323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
    Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
    mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir.
    Avalos CR; Abreu CM; Queen SE; Li M; Price S; Shirk EN; Engle EL; Forsyth E; Bullock BT; Mac Gabhann F; Wietgrefe SW; Haase AT; Zink MC; Mankowski JL; Clements JE; Gama L
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811349
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.